Proclara Biosciences, Inc.   Report issue

For profit Phase 1
Founded: Cambridge MA United States (2006)

Organization Overview

First Clinical Trial
2016
NCT03008161
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Proclara | Proclara Biosciences | Proclara Biosciences, Inc.

Active Ingredients

Drugs in Phase 1 Trials (2)

npt088 (1 trial)

npt189 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 1)

Amyloidosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 2